OTHER VOICES

Modern Healthcare - - Opinions Editorials -

“(CT) scans—a rapid se­ries of X-rays that pro­duces a highly detailed cross sec­tion of por­tions of the body—are draw­ing new scru­tiny from the fed­eral Food and Drug Ad­min­is­tra­tion. And that’s healthy. In re­cent days, the FDA an­nounced that it is mov­ing to tighten con­trols on med­i­cal imag­ing de­vices to make sure mis­takes are rare and scans are safer. … The FDA should act soon. It needs to or­der changes to the scan­ners so they will be cal­i­brated au­to­mat­i­cally to a rec­om­mended dose of ra­di­a­tion for a spe­cific pro­ce­dure. … The agency also plans to pro­mote a per­sonal med­i­cal imag­ing his­tory card.”

—ChicagoTri­bune “An­them Blue Cross, Cal­i­for­nia’s largest for-profit health in­surer, has an­nounced it will post­pone its planned 39% rate hike. … Rate hikes of this mag­ni­tude would prompt thou­sands of An­them’s 700,000-plus cus­tomers in Cal­i­for­nia to drop their in­di­vid­ual cov­er­age, putting more strain on emer­gency rooms. … Cal­i­for­nia must have a strat­egy to deal with in­sur­ance com­pa­nies that seek rate hikes above the inflation rate for med­i­cal costs. One op­tion is to reg­u­late in­sur­ance rates.”

—Fresno

Bee

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.